hotspot -WSS

hotspot

author：focus 2025-09-02 08:25:37 - browse：835

Beth Israel Deaconess Medical Center in Boston — David L. Ryan/The Boston Globe

Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry.

While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.

Industry leaders are calling for urgent action from the Healey administration and the Legislature to help stem the crisis. Even just simplifying the state regulatory bureaucracy and approvals for bringing uninsured patients into the MassHealth system would help, executives say.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Wife of Gilgo Beach murder suspect files for divorce, court filing shows

focus

WSS

The FDA must approve intranasal treatments for anaphylaxis

Why Congress must ban federal programs from using QALYs

White House finalizes ITC's import ban of latest Apple Watches

Stanford president faces new allegations over 1999 paper

A single drug, study failures leave Anavex with nothing but cash

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

hotspot

hotspot

knowledge

Tori Bowie and the unacceptable rates of Black maternal death

Stanford president faces new allegations over 1999 paper

Anesthesiologist group: stop taking Ozempic before surgery

Why psychiatrists like me stop taking insurance

What does generative AI mean for health care? We asked experts

Chronically ill young patients struggle to find fertility info

{$title}

Winning ticket for $1 billion Powerball jackpot sold in California

Hepatitis C has a cure — but many Americans still lack access to it

Indian pharmaceutical industry in denial over drug

focus

A single drug, study failures leave Anavex with nothing but cash

I learned firsthand about improving diversity in clinical trials

Mass General totes up its waste in a move to tackle climate change

UCB departs biotech trade group BIO

Feng Zhang CRISPR delivery startup lays off quarter of staff

7 more heat

knowledge

focus

focus

focus